Allogeneic hematopoietic stem cell transplantation for treating severe lung involvement in Gaucher disease

Objective: To provide strategies for monitoring and treating severe lung involvement in Gaucher disease. Study design: We reviewed the chart of a 5-year-old boy who developed rapidly progressive, severe infiltrative lung involvement of Gaucher disease (GD) and improved after allogeneic hematopoietic...

Full description

Bibliographic Details
Main Authors: Fu-Shiuan Lee, Hsiu-Ju Yen, Dau-Ming Niu, Giun-Yi Hung, Chih-Ying Lee, Yi-Chen Yeh, Paul Chih-Hsueh Chen, Sheng-Kai Chang, Chia-Feng Yang
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Molecular Genetics and Metabolism Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214426920300987
_version_ 1818952715240210432
author Fu-Shiuan Lee
Hsiu-Ju Yen
Dau-Ming Niu
Giun-Yi Hung
Chih-Ying Lee
Yi-Chen Yeh
Paul Chih-Hsueh Chen
Sheng-Kai Chang
Chia-Feng Yang
author_facet Fu-Shiuan Lee
Hsiu-Ju Yen
Dau-Ming Niu
Giun-Yi Hung
Chih-Ying Lee
Yi-Chen Yeh
Paul Chih-Hsueh Chen
Sheng-Kai Chang
Chia-Feng Yang
author_sort Fu-Shiuan Lee
collection DOAJ
description Objective: To provide strategies for monitoring and treating severe lung involvement in Gaucher disease. Study design: We reviewed the chart of a 5-year-old boy who developed rapidly progressive, severe infiltrative lung involvement of Gaucher disease (GD) and improved after allogeneic hematopoietic stem cell transplant (HSCT), along with other case studies reported before December 2019. He was diagnosed with GD (homozygous mutation at c.1448 T > C, p.L483P), and started receiving enzyme replacement therapy (ERT) at 17 months old. He developed respiratory distress symptoms after 45 months of ERT; chest imaging reported diffuse interstitial infiltration of the bilateral lungs and consolidations at the right lungs. Allogeneic HSCT using cells from a matched unrelated donor was performed four months upon progressive respiratory symptoms. Results: His respiratory symptoms subsided in one month; chest imaging improvement, pulmonary function test improvement, and normalized activity of β-glucocerebrosidase were reported in three months. Conclusion: This is the first report of a patient who received early and regular ERT but developed severe infiltrative lung involvement and recovered after allogeneic HSCT. Based on study results, we suggest regular chest imaging, even for asymptomatic patients. For patients with severe lung involvement, rapid deterioration, and unresponsive to higher ERT dosages, allogeneic HSCT should be considered.
first_indexed 2024-12-20T09:54:47Z
format Article
id doaj.art-7d0c48e7a2914dac87bf2baec12f3342
institution Directory Open Access Journal
issn 2214-4269
language English
last_indexed 2024-12-20T09:54:47Z
publishDate 2020-12-01
publisher Elsevier
record_format Article
series Molecular Genetics and Metabolism Reports
spelling doaj.art-7d0c48e7a2914dac87bf2baec12f33422022-12-21T19:44:29ZengElsevierMolecular Genetics and Metabolism Reports2214-42692020-12-0125100652Allogeneic hematopoietic stem cell transplantation for treating severe lung involvement in Gaucher diseaseFu-Shiuan Lee0Hsiu-Ju Yen1Dau-Ming Niu2Giun-Yi Hung3Chih-Ying Lee4Yi-Chen Yeh5Paul Chih-Hsueh Chen6Sheng-Kai Chang7Chia-Feng Yang8Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang-Ming University, Taipei, TaiwanDepartment of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang-Ming University, Taipei, TaiwanDepartment of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang-Ming University, Taipei, TaiwanDepartment of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang-Ming University, Taipei, TaiwanDepartment of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang-Ming University, Taipei, TaiwanSchool of Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, TaiwanSchool of Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, TaiwanDepartment of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang-Ming University, Taipei, TaiwanDepartment of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang-Ming University, Taipei, Taiwan; Corresponding author at: Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan.Objective: To provide strategies for monitoring and treating severe lung involvement in Gaucher disease. Study design: We reviewed the chart of a 5-year-old boy who developed rapidly progressive, severe infiltrative lung involvement of Gaucher disease (GD) and improved after allogeneic hematopoietic stem cell transplant (HSCT), along with other case studies reported before December 2019. He was diagnosed with GD (homozygous mutation at c.1448 T > C, p.L483P), and started receiving enzyme replacement therapy (ERT) at 17 months old. He developed respiratory distress symptoms after 45 months of ERT; chest imaging reported diffuse interstitial infiltration of the bilateral lungs and consolidations at the right lungs. Allogeneic HSCT using cells from a matched unrelated donor was performed four months upon progressive respiratory symptoms. Results: His respiratory symptoms subsided in one month; chest imaging improvement, pulmonary function test improvement, and normalized activity of β-glucocerebrosidase were reported in three months. Conclusion: This is the first report of a patient who received early and regular ERT but developed severe infiltrative lung involvement and recovered after allogeneic HSCT. Based on study results, we suggest regular chest imaging, even for asymptomatic patients. For patients with severe lung involvement, rapid deterioration, and unresponsive to higher ERT dosages, allogeneic HSCT should be considered.http://www.sciencedirect.com/science/article/pii/S2214426920300987Lysosomal storage diseaseInfiltrative lung diseaseGlucocerebrosidase
spellingShingle Fu-Shiuan Lee
Hsiu-Ju Yen
Dau-Ming Niu
Giun-Yi Hung
Chih-Ying Lee
Yi-Chen Yeh
Paul Chih-Hsueh Chen
Sheng-Kai Chang
Chia-Feng Yang
Allogeneic hematopoietic stem cell transplantation for treating severe lung involvement in Gaucher disease
Molecular Genetics and Metabolism Reports
Lysosomal storage disease
Infiltrative lung disease
Glucocerebrosidase
title Allogeneic hematopoietic stem cell transplantation for treating severe lung involvement in Gaucher disease
title_full Allogeneic hematopoietic stem cell transplantation for treating severe lung involvement in Gaucher disease
title_fullStr Allogeneic hematopoietic stem cell transplantation for treating severe lung involvement in Gaucher disease
title_full_unstemmed Allogeneic hematopoietic stem cell transplantation for treating severe lung involvement in Gaucher disease
title_short Allogeneic hematopoietic stem cell transplantation for treating severe lung involvement in Gaucher disease
title_sort allogeneic hematopoietic stem cell transplantation for treating severe lung involvement in gaucher disease
topic Lysosomal storage disease
Infiltrative lung disease
Glucocerebrosidase
url http://www.sciencedirect.com/science/article/pii/S2214426920300987
work_keys_str_mv AT fushiuanlee allogeneichematopoieticstemcelltransplantationfortreatingseverelunginvolvementingaucherdisease
AT hsiujuyen allogeneichematopoieticstemcelltransplantationfortreatingseverelunginvolvementingaucherdisease
AT daumingniu allogeneichematopoieticstemcelltransplantationfortreatingseverelunginvolvementingaucherdisease
AT giunyihung allogeneichematopoieticstemcelltransplantationfortreatingseverelunginvolvementingaucherdisease
AT chihyinglee allogeneichematopoieticstemcelltransplantationfortreatingseverelunginvolvementingaucherdisease
AT yichenyeh allogeneichematopoieticstemcelltransplantationfortreatingseverelunginvolvementingaucherdisease
AT paulchihhsuehchen allogeneichematopoieticstemcelltransplantationfortreatingseverelunginvolvementingaucherdisease
AT shengkaichang allogeneichematopoieticstemcelltransplantationfortreatingseverelunginvolvementingaucherdisease
AT chiafengyang allogeneichematopoieticstemcelltransplantationfortreatingseverelunginvolvementingaucherdisease